Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Acquired Immunodeficiency Syndrome
Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma.
Acquired Immunodeficiency Syndrome
Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Acrospiroma
The utility of using immunohistochemistry in the differentiation of metastatic, cutaneous clear cell renal cell carcinoma and clear cell hidradenoma.
Adenocarcinoma
A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
Adenocarcinoma
A study of immunohistochemical differential expression in pulmonary and mammary carcinomas.
Adenocarcinoma
Aberrant expression of napsin A in a subset of malignant lymphomas.
Adenocarcinoma
Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer.
Adenocarcinoma
ALK and ROS1 rearrangements, coexistence and treatment in epidermal growth factor receptor-wild type lung adenocarcinoma: a multicenter study of 732 cases.
Adenocarcinoma
Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.
Adenocarcinoma
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Adenocarcinoma
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Adenocarcinoma
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Adenocarcinoma
Close relation of large cell carcinoma to adenocarcinoma by hierarchical cluster analysis: implications for histologic typing of lung cancer on biopsies.
Adenocarcinoma
Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
Adenocarcinoma
Combination of Napsin A and TTF-1 Immunohistochemistry Helps in Differentiating Primary Lung Adenocarcinoma From Metastatic Carcinoma in the Lung.
Adenocarcinoma
Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas.
Adenocarcinoma
Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas.
Adenocarcinoma
Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Adenocarcinoma
Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes.
Adenocarcinoma
Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Adenocarcinoma
Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.
Adenocarcinoma
Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
Adenocarcinoma
Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Adenocarcinoma
Histopathological Spectrum and Immunohistochemical Profile of Lung Carcinomas: A 9-Year Study from a Tertiary Hospital in North India.
Adenocarcinoma
Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.
Adenocarcinoma
Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
Adenocarcinoma
Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma--sensitivity of TTF-1 is superior to napsin.
Adenocarcinoma
Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma.
Adenocarcinoma
IMP3 can predict aggressive behaviour of lung adenocarcinoma.
Adenocarcinoma
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis.
Adenocarcinoma
KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.
Adenocarcinoma
Lung cancer histologic and immunohistochemical heterogeneity in the era of molecular therapies: analysis of 172 consecutive surgically resected, entirely sampled pulmonary carcinomas.
Adenocarcinoma
Maintenance therapy for advanced lung cancer: who, what, and when?
Adenocarcinoma
Malignant mesothelioma: A histomorphological and immunohistochemical study of 24 cases from a tertiary care hospital in Southern India.
Adenocarcinoma
Mesothelioma with signet-ring cell features: report of 23 cases.
Adenocarcinoma
Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer.
Adenocarcinoma
Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
Adenocarcinoma
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Adenocarcinoma
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Adenocarcinoma
Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Adenocarcinoma
Napsin A Expression in Human Tumors and Normal Tissues.
Adenocarcinoma
Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study.
Adenocarcinoma
Napsin A expression in small cell carcinoma of the lung: a cytologic study with review of differentials.
Adenocarcinoma
Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Adenocarcinoma
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Adenocarcinoma
Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin.
Adenocarcinoma
Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung.
Adenocarcinoma
Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
Adenocarcinoma
Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs.
Adenocarcinoma
Napsin-A, A Possible Diagnostic Marker for Differentiating Clear Cell Ovarian Carcinoma From Other High-grade Ovarian Carcinomas.
Adenocarcinoma
Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
Adenocarcinoma
New immunohistochemical markers in the differential diagnosisof nonsmall cell lung carcinoma.
Adenocarcinoma
Newly available antibodies with practical applications in surgical pathology.
Adenocarcinoma
Non-sarcomatous spindle cell morphology in conventional lung adenocarcinoma: a clinicopathological study.
Adenocarcinoma
Novel gene mutations in well-differentiated fetal adenocarcinoma of the lung in the next generation sequencing era.
Adenocarcinoma
Occult carcinoma confirmed to be a diffuse sclerosing variant of papillary thyroid carcinoma with unusual immunohistochemical features: A pitfall of clinicopathological diagnosis.
Adenocarcinoma
PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis.
Adenocarcinoma
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Adenocarcinoma
Primary Vaginal Gastric-type Adenocarcinoma and Vaginal Adenosis Exhibiting Gastric Differentiation: Report of a Series With Detailed Immunohistochemical Analysis.
Adenocarcinoma
Pten and Dicer1 loss in the mouse uterus causes poorly differentiated endometrial adenocarcinoma.
Adenocarcinoma
Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas.
Adenocarcinoma
Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.
Adenocarcinoma
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Adenocarcinoma
Pulmonary-type adenocarcinoma and signet ring mucinous adenocarcinoma arising in an ovarian dermoid cyst: report of a unique case.
Adenocarcinoma
Rapid Multiplex Immunohistochemistry Using the 4-antibody Cocktail YANA-4 in Differentiating Primary Adenocarcinoma From Squamous Cell Carcinoma of the Lung.
Adenocarcinoma
Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
Adenocarcinoma
Role of Napsin A and Survivin Immunohistochemical Expression in Bronchogenic Adenocarcinoma.
Adenocarcinoma
S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.
Adenocarcinoma
The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma.
Adenocarcinoma
The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.
Adenocarcinoma
The use of placental S100 (S100P), GATA3 and napsin A in the differential diagnosis of primary adenocarcinoma of the bladder and bladder metastasis from adenocarcinoma of the lung.
Adenocarcinoma
The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
Adenocarcinoma
Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma.
Adenocarcinoma
TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel.
Adenocarcinoma
TTF-1 and Napsin-A Are Not Markers for Biliary Phenotype: An Immunohistochemical Study of Gallbladder Adenocarcinomas.
Adenocarcinoma
TTF-1, napsin A and CDX2 co-expression in metastatic rectal adenocarcinoma to the lung.
Adenocarcinoma
Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases.
Adenocarcinoma
Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion.
Adenocarcinoma
Utility of TTF-1 and Napsin-A in the work-up of malignant effusions.
Adenocarcinoma
Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
Adenocarcinoma
Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma.
Adenocarcinoma
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
Adenocarcinoma
[A Case of Lung Metastasis Occurring Four Years after Pancreaticoduodenectomy for Pancreatic Cancer].
Adenocarcinoma
[A case of resectable lung metastasis one year six months after surgery for pancreatic cancer].
Adenocarcinoma
[Combined detection of thyroid transcription factor 1 and napsin A in pleural fluid cell blocks facilitates cytopathologic diagnosis of pulmonary adenocarcinoma].
Adenocarcinoma
[Diagnosis value of TTF-1, Napsin A and Ki-67 index in primary salivary gland-type lung carcinomas].
Adenocarcinoma
[Prostate Carcinoma Mimics Lung Carcinoma: A Case Report].
Adenocarcinoma
[Two synchronous malignancies in a single nephrectomy specimen].
Adenocarcinoma of Lung
A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa.
Adenocarcinoma of Lung
A word of caution regarding napsin a expression in squamous cell carcinomas of the lung.
Adenocarcinoma of Lung
Adenocarcinoma of the Lung Metastatic to the Ovary With a Signet Ring Cell Component.
Adenocarcinoma of Lung
ALK-positive adenocarcinoma of the lung expressing neuroendocrine markers and presenting as a "pituitary adenoma".
Adenocarcinoma of Lung
An ALK-positive lung adenocarcinoma with gastric and skin metastasis: a case report and literature review.
Adenocarcinoma of Lung
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Adenocarcinoma of Lung
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Adenocarcinoma of Lung
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Adenocarcinoma of Lung
Case Report: Next-Generation Sequencing Reveals Tumor Origin in a Female Patient With Brain Metastases.
Adenocarcinoma of Lung
CDX-2 Expression in Primary Lung Adenocarcinoma.
Adenocarcinoma of Lung
Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
Adenocarcinoma of Lung
Clinicopathological and Prognostic Significance of the EML4-ALK Translocation and IGFR1, TTF1, Napsin A Expression in Patients with Lung Adenocarcinoma.
Adenocarcinoma of Lung
Combination of Napsin A and TTF-1 Immunohistochemistry Helps in Differentiating Primary Lung Adenocarcinoma From Metastatic Carcinoma in the Lung.
Adenocarcinoma of Lung
Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas.
Adenocarcinoma of Lung
Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Adenocarcinoma of Lung
Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.
Adenocarcinoma of Lung
EGFR Mutated Lung Adenocarcinoma Metastasis to the Pancreas Mimicking Primary Pancreatic Ductal Carcinoma.
Adenocarcinoma of Lung
Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
Adenocarcinoma of Lung
Folate Receptor ? Expression Level Correlates With Histologic Grade in Lung Adenocarcinoma.
Adenocarcinoma of Lung
Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A.
Adenocarcinoma of Lung
Immunoexpression of napsin A in renal neoplasms.
Adenocarcinoma of Lung
Immunohistochemical analysis and comparison of napsin A, TTF1, SPA and CK7 expression in primary lung adenocarcinoma.
Adenocarcinoma of Lung
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
Adenocarcinoma of Lung
IMP3 can predict aggressive behaviour of lung adenocarcinoma.
Adenocarcinoma of Lung
Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Adenocarcinoma of Lung
Intracranial Meningioma as Initial Clinical Manifestation of Occult Lung Carcinoma: Case Report.
Adenocarcinoma of Lung
KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.
Adenocarcinoma of Lung
Lepidic and micropapillary growth pattern and expression of Napsin A can stratify patients of stage I lung adenocarcinoma into different prognostic subgroup.
Adenocarcinoma of Lung
Leukoerythroblastosis with Cytopenia as an Initial Presentation of Lung Adenocarcinoma.
Adenocarcinoma of Lung
Mesothelioma with signet-ring cell features: report of 23 cases.
Adenocarcinoma of Lung
MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung.
Adenocarcinoma of Lung
Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma.
Adenocarcinoma of Lung
Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
Adenocarcinoma of Lung
Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Adenocarcinoma of Lung
Napsin A expression in lung and kidney neoplasia: a review and update.
Adenocarcinoma of Lung
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Adenocarcinoma of Lung
Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Adenocarcinoma of Lung
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Adenocarcinoma of Lung
Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung.
Adenocarcinoma of Lung
Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs.
Adenocarcinoma of Lung
Napsin A levels in epithelial lining fluid as a diagnostic biomarker of primary lung adenocarcinoma.
Adenocarcinoma of Lung
Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas.
Adenocarcinoma of Lung
Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.
Adenocarcinoma of Lung
p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63.
Adenocarcinoma of Lung
Pepstatin pull-down at high pH is a powerful tool for detection and analysis of napsin A.
Adenocarcinoma of Lung
Poorly differentiated adenocarcinoma of an unknown primary with a thyroid tumour and an aggressive course: thyroid or lung carcinoma?
Adenocarcinoma of Lung
Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations.
Adenocarcinoma of Lung
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Adenocarcinoma of Lung
Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
Adenocarcinoma of Lung
Role of Napsin A and Survivin Immunohistochemical Expression in Bronchogenic Adenocarcinoma.
Adenocarcinoma of Lung
Role of Napsin A and TTF1 as a diagnostic marker for lung adenocarcinoma.
Adenocarcinoma of Lung
SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma.
Adenocarcinoma of Lung
Surgical treatment of bone metastasis followed by a primary lung cancer lesion: report of a case.
Adenocarcinoma of Lung
The application of immunocytochemistry to direct smears in the diagnosis of effusions.
Adenocarcinoma of Lung
The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity.
Adenocarcinoma of Lung
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
Adenocarcinoma of Lung
The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment.
Adenocarcinoma of Lung
The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis.
Adenocarcinoma of Lung
The use of placental S100 (S100P), GATA3 and napsin A in the differential diagnosis of primary adenocarcinoma of the bladder and bladder metastasis from adenocarcinoma of the lung.
Adenocarcinoma of Lung
The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
Adenocarcinoma of Lung
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia.
Adenocarcinoma of Lung
Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma.
Adenocarcinoma of Lung
Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid.
Adenocarcinoma of Lung
TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel.
Adenocarcinoma of Lung
TTF-1 and Napsin A double stain: A useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks.
Adenocarcinoma of Lung
TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.
Adenocarcinoma of Lung
Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study.
Adenocarcinoma of Lung
Update on Immunohistochemical Analysis in Breast Lesions.
Adenocarcinoma of Lung
Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma.
Adenocarcinoma of Lung
[Clinicopathological and Prognostic Significance of a Panel of Tumor Biomarkers ?in Lung Adenocarcinoma: a Tissue Microarray Study].
Adenocarcinoma, Bronchiolo-Alveolar
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Adenocarcinoma, Bronchiolo-Alveolar
Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study.
Adenocarcinoma, Clear Cell
Napsin A Expression in Human Tumors and Normal Tissues.
Adenocarcinoma, Clear Cell
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Adenocarcinoma, Mucinous
Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas.
Adenocarcinoma, Mucinous
Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma.
Adenocarcinoma, Mucinous
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Adenocarcinoma, Mucinous
Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study.
Adenocarcinoma, Mucinous
Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
Adenocarcinoma, Mucinous
Nonspecific Reactivity of Polyclonal Napsin A Antibody in Mucinous Adenocarcinomas of Various Sites: A Word of Caution.
Adenofibroma
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Adenofibroma
Recurrent NAB2-STAT6 gene fusions and oestrogen receptor-? expression in pulmonary adenofibromas.
Adenoma
Epithelial and organ-related marker expression in pituitary adenomas.
Adenoma
Immunoexpression of napsin A in renal neoplasms.
Adenoma
Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Adenoma, Oxyphilic
Immunoexpression of napsin A in renal neoplasms.
Breast Neoplasms
A study of immunohistochemical differential expression in pulmonary and mammary carcinomas.
Breast Neoplasms
Aberrant Expression of Napsin A in Breast Carcinoma With Apocrine Features.
Breast Neoplasms
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Breast Neoplasms
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Breast Neoplasms
Update on Immunohistochemical Analysis in Breast Lesions.
Carcinoid Tumor
Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
Carcinoid Tumor
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Carcinoma
A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
Carcinoma
A study of immunohistochemical differential expression in pulmonary and mammary carcinomas.
Carcinoma
A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa.
Carcinoma
A word of caution regarding napsin a expression in squamous cell carcinomas of the lung.
Carcinoma
Aberrant expression of napsin A in a subset of malignant lymphomas.
Carcinoma
Aberrant Expression of Napsin A in Breast Carcinoma With Apocrine Features.
Carcinoma
Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer.
Carcinoma
Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.
Carcinoma
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Carcinoma
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Carcinoma
Calibration and Optimization of p53, WT1, and Napsin A Immunohistochemistry Ancillary Tests for Histotyping of Ovarian Carcinoma: Canadian Immunohistochemistry Quality Control (CIQC) Experience.
Carcinoma
Can We Tell the Site of Origin of Metastatic Squamous Cell Carcinoma? An Immunohistochemical Tissue Microarray Study of 194 Cases.
Carcinoma
Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
Carcinoma
Clear Cell Renal Cell Carcinoma Metastatic to the Gynecologic Tract: A Clinicopathologic Analysis of 17 Cases.
Carcinoma
Close relation of large cell carcinoma to adenocarcinoma by hierarchical cluster analysis: implications for histologic typing of lung cancer on biopsies.
Carcinoma
Combination of Napsin A and TTF-1 Immunohistochemistry Helps in Differentiating Primary Lung Adenocarcinoma From Metastatic Carcinoma in the Lung.
Carcinoma
Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
Carcinoma
Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas.
Carcinoma
Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
Carcinoma
Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas.
Carcinoma
Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Carcinoma
Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes.
Carcinoma
Despite Diagnostic Morphology, Many Mixed Endometrial Carcinomas Show Unexpected Immunohistochemical Staining Patterns.
Carcinoma
Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
Carcinoma
Diagnostic and Prognostic Role of Immunohistochemical Expression of Napsin-A Aspartic Peptidase in Clear Cell and Papillary Renal Cell Carcinoma: A Study Including 233 Primary and Metastatic Cases.
Carcinoma
Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Carcinoma
Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1?) and napsin A for diagnosing ovarian clear cell carcinoma.
Carcinoma
Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.
Carcinoma
Endometrial clear cell carcinoma invading the right oviduct with a cooccurring ipsilateral oviduct adenomatoid tumor: A case report.
Carcinoma
Endometrial Tumor Classification by Histomorphology and Biomarkers in the Nurses' Health Study.
Carcinoma
Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
Carcinoma
Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
Carcinoma
Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Carcinoma
Fine-needle aspiration cytology of non-small cell lung carcinoma: A paradigm shift.
Carcinoma
Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.
Carcinoma
Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.
Carcinoma
High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
Carcinoma
Histopathological Spectrum and Immunohistochemical Profile of Lung Carcinomas: A 9-Year Study from a Tertiary Hospital in North India.
Carcinoma
Immunoexpression of napsin A in renal neoplasms.
Carcinoma
Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
Carcinoma
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
Carcinoma
Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma--sensitivity of TTF-1 is superior to napsin.
Carcinoma
Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma.
Carcinoma
Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Carcinoma
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis.
Carcinoma
Lung cancer histologic and immunohistochemical heterogeneity in the era of molecular therapies: analysis of 172 consecutive surgically resected, entirely sampled pulmonary carcinomas.
Carcinoma
Mesothelioma with signet-ring cell features: report of 23 cases.
Carcinoma
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Carcinoma
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Carcinoma
Napsin A as a marker of clear cell ovarian carcinoma.
Carcinoma
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Carcinoma
Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Carcinoma
Napsin A Expression in Human Tumors and Normal Tissues.
Carcinoma
Napsin A expression in lung and kidney neoplasia: a review and update.
Carcinoma
Napsin A expression in small cell carcinoma of the lung: a cytologic study with review of differentials.
Carcinoma
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Carcinoma
Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Carcinoma
Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
Carcinoma
Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs.
Carcinoma
Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.
Carcinoma
Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
Carcinoma
Napsin A: Another milestone in the subclassification of ovarian carcinoma.
Carcinoma
Napsin-A and AMACR are Superior to HNF-1? in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract.
Carcinoma
Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas.
Carcinoma
Napsin-A, A Possible Diagnostic Marker for Differentiating Clear Cell Ovarian Carcinoma From Other High-grade Ovarian Carcinomas.
Carcinoma
New immunohistochemical markers in the differential diagnosisof nonsmall cell lung carcinoma.
Carcinoma
Numerous osteoclast-like giant cells in metastases from lung adenocarcinoma, but absent from primary tumor.
Carcinoma
Occult ovarian clear-cell carcinoma diagnosed as primary adenocarcinoma of the lung: A case report of a diagnostic pitfall for clinicians and pathologists.
Carcinoma
Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions.
Carcinoma
p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63.
Carcinoma
Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
Carcinoma
PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis.
Carcinoma
Pepstatin pull-down at high pH is a powerful tool for detection and analysis of napsin A.
Carcinoma
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Carcinoma
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Carcinoma
Raspberry bodies and hyaline globules with positive napsin A immunoexpression are useful features in diagnosing clear cell carcinoma of the female genital tract in cytology samples.
Carcinoma
Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
Carcinoma
Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A.
Carcinoma
Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
Carcinoma
Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma?
Carcinoma
Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance: A case report.
Carcinoma
Spindle cell and pleomorphic ("sarcomatoid") carcinomas of the lung: an immunohistochemical analysis of 86 cases.
Carcinoma
Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
Carcinoma
Surfactant Protein A and Napsin A in the Immunohistochemical Characterization of Canine Pulmonary Carcinomas: Comparison With Thyroid Transcription Factor-1.
Carcinoma
The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity.
Carcinoma
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
Carcinoma
The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes.
Carcinoma
The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis.
Carcinoma
The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary.
Carcinoma
The role of Napsin-A and Desmocollin-3 in classifying poorly differentiating non-small cell lung carcinoma.
Carcinoma
The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
Carcinoma
The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
Carcinoma
Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study.
Carcinoma
Unusual expression of thyroid transcription factor 1 and napsin a in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung.
Carcinoma
Use of Immunohistochemical Markers (HNF-1?, Napsin A, ER, CTH, and ASS1) to Distinguish Endometrial Clear Cell Carcinoma From Its Morphologic Mimics Including Arias-Stella Reaction.
Carcinoma
Utility of a Novel Triple Marker (Combination of TTF-1, Napsin-A and P40) in the Subclassification of Non-Small Cell Lung Carcinomas using Fine Needle Aspiration Cases.
Carcinoma
Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases.
Carcinoma
Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma.
Carcinoma
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
Carcinoma
[Clinicopathologic features and genetic profile of the redefined large cell lung carcinoma].
Carcinoma
[Diagnosis value of TTF-1, Napsin A and Ki-67 index in primary salivary gland-type lung carcinomas].
Carcinoma
[Diagnostic and prognostic implications of MAML2 gene translocation in primary pulmonary mucoepidermoid carcinoma].
Carcinoma
[Diagnostic value of combined detection of HNF-1? and Napsin A in the diagnosis of ovarian clear cell carcinoma].
Carcinoma
[Prostate Carcinoma Mimics Lung Carcinoma: A Case Report].
Carcinoma, Adenoid Cystic
Unusual expression of thyroid transcription factor 1 and napsin a in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung.
Carcinoma, Adenosquamous
[Diagnosis value of TTF-1, Napsin A and Ki-67 index in primary salivary gland-type lung carcinomas].
Carcinoma, Bronchogenic
Role of Napsin A and Survivin Immunohistochemical Expression in Bronchogenic Adenocarcinoma.
Carcinoma, Endometrioid
Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
Carcinoma, Endometrioid
Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
Carcinoma, Endometrioid
Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1?) and napsin A for diagnosing ovarian clear cell carcinoma.
Carcinoma, Endometrioid
Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.
Carcinoma, Endometrioid
Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Carcinoma, Endometrioid
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Carcinoma, Endometrioid
Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
Carcinoma, Endometrioid
[Diagnostic value of combined detection of HNF-1? and Napsin A in the diagnosis of ovarian clear cell carcinoma].
Carcinoma, Hepatocellular
Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature.
Carcinoma, Large Cell
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Carcinoma, Large Cell
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Carcinoma, Large Cell
Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
Carcinoma, Large Cell
Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A.
Carcinoma, Neuroendocrine
Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
Carcinoma, Neuroendocrine
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Carcinoma, Neuroendocrine
Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A.
Carcinoma, Neuroendocrine
Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases.
Carcinoma, Non-Small-Cell Lung
?Np63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens.
Carcinoma, Non-Small-Cell Lung
Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Carcinoma, Non-Small-Cell Lung
Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Carcinoma, Non-Small-Cell Lung
Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma.
Carcinoma, Non-Small-Cell Lung
Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
Carcinoma, Non-Small-Cell Lung
New immunohistochemical markers in the differential diagnosisof nonsmall cell lung carcinoma.
Carcinoma, Non-Small-Cell Lung
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Carcinoma, Non-Small-Cell Lung
Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
Carcinoma, Non-Small-Cell Lung
The role of Napsin-A and Desmocollin-3 in classifying poorly differentiating non-small cell lung carcinoma.
Carcinoma, Non-Small-Cell Lung
The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
Carcinoma, Non-Small-Cell Lung
[Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases].
Carcinoma, Ovarian Epithelial
Napsin-A, A Possible Diagnostic Marker for Differentiating Clear Cell Ovarian Carcinoma From Other High-grade Ovarian Carcinomas.
Carcinoma, Papillary
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Carcinoma, Papillary
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
Carcinoma, Renal Cell
A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa.
Carcinoma, Renal Cell
Aberrant expression of napsin A in a subset of malignant lymphomas.
Carcinoma, Renal Cell
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Carcinoma, Renal Cell
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Carcinoma, Renal Cell
Clear Cell Renal Cell Carcinoma Metastatic to the Gynecologic Tract: A Clinicopathologic Analysis of 17 Cases.
Carcinoma, Renal Cell
Combination of Napsin A and TTF-1 Immunohistochemistry Helps in Differentiating Primary Lung Adenocarcinoma From Metastatic Carcinoma in the Lung.
Carcinoma, Renal Cell
Diagnostic and Prognostic Role of Immunohistochemical Expression of Napsin-A Aspartic Peptidase in Clear Cell and Papillary Renal Cell Carcinoma: A Study Including 233 Primary and Metastatic Cases.
Carcinoma, Renal Cell
Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Carcinoma, Renal Cell
Immunoexpression of napsin A in renal neoplasms.
Carcinoma, Renal Cell
Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
Carcinoma, Renal Cell
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
Carcinoma, Renal Cell
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Carcinoma, Renal Cell
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Carcinoma, Renal Cell
Napsin A Expression in Human Tumors and Normal Tissues.
Carcinoma, Renal Cell
Napsin A expression in lung and kidney neoplasia: a review and update.
Carcinoma, Renal Cell
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Carcinoma, Renal Cell
Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
Carcinoma, Renal Cell
The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity.
Carcinoma, Renal Cell
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
Carcinoma, Renal Cell
The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
Carcinoma, Renal Cell
Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study.
Carcinoma, Renal Cell
Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma.
Carcinoma, Small Cell
Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
Carcinoma, Small Cell
Napsin A expression in small cell carcinoma of the lung: a cytologic study with review of differentials.
Carcinoma, Small Cell
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Carcinoma, Small Cell
Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance: A case report.
Carcinoma, Small Cell
The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
Carcinoma, Squamous Cell
A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
Carcinoma, Squamous Cell
A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa.
Carcinoma, Squamous Cell
A word of caution regarding napsin a expression in squamous cell carcinomas of the lung.
Carcinoma, Squamous Cell
Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer.
Carcinoma, Squamous Cell
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Carcinoma, Squamous Cell
Can We Tell the Site of Origin of Metastatic Squamous Cell Carcinoma? An Immunohistochemical Tissue Microarray Study of 194 Cases.
Carcinoma, Squamous Cell
Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
Carcinoma, Squamous Cell
Close relation of large cell carcinoma to adenocarcinoma by hierarchical cluster analysis: implications for histologic typing of lung cancer on biopsies.
Carcinoma, Squamous Cell
Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Carcinoma, Squamous Cell
Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes.
Carcinoma, Squamous Cell
Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.
Carcinoma, Squamous Cell
Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
Carcinoma, Squamous Cell
Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Carcinoma, Squamous Cell
Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.
Carcinoma, Squamous Cell
Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma.
Carcinoma, Squamous Cell
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis.
Carcinoma, Squamous Cell
Lung cancer histologic and immunohistochemical heterogeneity in the era of molecular therapies: analysis of 172 consecutive surgically resected, entirely sampled pulmonary carcinomas.
Carcinoma, Squamous Cell
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Carcinoma, Squamous Cell
Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Carcinoma, Squamous Cell
New immunohistochemical markers in the differential diagnosisof nonsmall cell lung carcinoma.
Carcinoma, Squamous Cell
p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63.
Carcinoma, Squamous Cell
PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis.
Carcinoma, Squamous Cell
Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
Carcinoma, Squamous Cell
S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.
Carcinoma, Squamous Cell
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
Carcinoma, Squamous Cell
The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis.
Carcinoma, Squamous Cell
The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
Carcinoma, Squamous Cell
Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases.
Carcinoma, Squamous Cell
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
Carcinosarcoma
Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
Cerebellar Neoplasms
Napsin a and thyroid transcription factor-1-positive cerebellar tumor with epidermal growth factor receptor mutation.
Cholangiocarcinoma
TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.
Colorectal Neoplasms
A case of napsin A-positive metastatic lung cancer originating from the colon.
Colorectal Neoplasms
Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas.
Colorectal Neoplasms
Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.
Confusion
Expression of Markers of Müllerian Clear Cell Carcinoma in Primary Cervical and Vaginal Gastric-type Adenocarcinomas.
Confusion
Unexpected TTF-1 Positivity in a Subset of Gastric Adenocarcinomas.
Cystadenofibroma
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Endodermal Sinus Tumor
Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
Endodermal Sinus Tumor
Endometrial tumors with yolk sac tumor-like morphologic patterns or immunophenotypes: an expanded appraisal.
Endodermal Sinus Tumor
High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.
Endodermal Sinus Tumor
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Endometrial Neoplasms
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Endometrial Neoplasms
Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
Endometrial Neoplasms
Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.
Endometrial Neoplasms
Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Endometrial Neoplasms
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Endometrial Neoplasms
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
Endometriosis
Abdominal Wall Clear Cell Carcinoma: Case Report of a Rare Event with Potential Diagnostic Difficulties.
Histiocytoma, Benign Fibrous
Napsin A is differentially expressed in sclerosing hemangiomas of the lung.
Idiopathic Pulmonary Fibrosis
The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.
Kidney Diseases
The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.
Kidney Neoplasms
Immunoexpression of napsin A in renal neoplasms.
Krukenberg Tumor
Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1?) and napsin A for diagnosing ovarian clear cell carcinoma.
Krukenberg Tumor
[Diagnostic value of combined detection of HNF-1? and Napsin A in the diagnosis of ovarian clear cell carcinoma].
Lung Neoplasms
?Np63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens.
Lung Neoplasms
A case of napsin A-positive metastatic lung cancer originating from the colon.
Lung Neoplasms
Automated Immunohistochemistry Assay for the Detection of Napsin-A in Formalin-Fixed Paraffin-Embedded Tissues from Lung Tumors.
Lung Neoplasms
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Lung Neoplasms
Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Lung Neoplasms
Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
Lung Neoplasms
Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Lung Neoplasms
Generation and evaluation of a monoclonal antibody, designated MAdL, as a new specific marker for adenocarcinomas of the lung.
Lung Neoplasms
Immunohistochemical analysis and comparison of napsin A, TTF1, SPA and CK7 expression in primary lung adenocarcinoma.
Lung Neoplasms
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
Lung Neoplasms
IMP3 can predict aggressive behaviour of lung adenocarcinoma.
Lung Neoplasms
Metastatic lung adenocarcinoma to the kidney diagnosed by urine cytology: a case report.
Lung Neoplasms
Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer.
Lung Neoplasms
Napsin A is differentially expressed in sclerosing hemangiomas of the lung.
Lung Neoplasms
Napsin A is negatively associated with EMT?mediated EGFR?TKI resistance in lung cancer cells.
Lung Neoplasms
New immunohistochemical markers in the differential diagnosisof nonsmall cell lung carcinoma.
Lung Neoplasms
Occult ovarian clear-cell carcinoma diagnosed as primary adenocarcinoma of the lung: A case report of a diagnostic pitfall for clinicians and pathologists.
Lung Neoplasms
Overexpression of Napsin A resensitizes drug-resistant lung cancer A549 cells to gefitinib by inhibiting EMT.
Lung Neoplasms
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Lung Neoplasms
S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.
Lung Neoplasms
Surfactant Protein A and Napsin A in the Immunohistochemical Characterization of Canine Pulmonary Carcinomas: Comparison With Thyroid Transcription Factor-1.
Lung Neoplasms
The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.
Lung Neoplasms
Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma.
Lung Neoplasms
[A Case of Metastatic Small Intestinal Tumor Diagnosed with Intestinal Obstruction].
Lung Neoplasms
[Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases].
Lymphatic Metastasis
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Lymphatic Metastasis
Unexpected TTF-1 Positivity in a Subset of Gastric Adenocarcinomas.
Lymphoma
A rare case of primary peripheral epithelial myoepithelial carcinoma of lung: Case report and literature review.
Lymphoma
Aberrant expression of napsin A in a subset of malignant lymphomas.
Lymphoma
Immunohistochemical Profiling of ALK Fusion Gene-Positive Adenocarcinomas of the Lung.
Lymphoma
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy.
Lymphoma
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Lymphoma
Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
Lymphoma
Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study.
Lymphoma
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia.
Lymphoma, B-Cell
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Lymphoma, Large B-Cell, Diffuse
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Mesothelioma
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Mesothelioma
Malignant mesothelioma: A histomorphological and immunohistochemical study of 24 cases from a tertiary care hospital in Southern India.
Mesothelioma
Mesothelioma with signet-ring cell features: report of 23 cases.
Mesothelioma
Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma.
Mesothelioma
Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
Mesothelioma
Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma.
Mesothelioma, Malignant
Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
Mesothelioma, Malignant
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Neoplasm Metastasis
A case of napsin A-positive metastatic lung cancer originating from the colon.
Neoplasm Metastasis
A study of immunohistochemical differential expression in pulmonary and mammary carcinomas.
Neoplasm Metastasis
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Neoplasm Metastasis
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Neoplasm Metastasis
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Neoplasm Metastasis
Case Report: Next-Generation Sequencing Reveals Tumor Origin in a Female Patient With Brain Metastases.
Neoplasm Metastasis
EGFR Mutated Lung Adenocarcinoma Metastasis to the Pancreas Mimicking Primary Pancreatic Ductal Carcinoma.
Neoplasm Metastasis
Epithelial and organ-related marker expression in pituitary adenomas.
Neoplasm Metastasis
Gastric metastasis from primary lung adenocarcinoma mimicking primary gastric cancer.
Neoplasm Metastasis
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
Neoplasm Metastasis
Initial clinical presentation of single soft tissue metastasis of medullary thyroid carcinoma without primary tumor in the thyroid gland.
Neoplasm Metastasis
Intracranial Meningioma as Initial Clinical Manifestation of Occult Lung Carcinoma: Case Report.
Neoplasm Metastasis
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Neoplasm Metastasis
Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
Neoplasm Metastasis
Proteomic analysis of laser-microdissected paraffin-embedded tissues: (2) MRM assay for stage-related proteins upon non-metastatic lung adenocarcinoma.
Neoplasm Metastasis
Role of conventional immunomarkers, HNF4-? and SATB2, in the differential diagnosis of pulmonary and colorectal adenocarcinomas.
Neoplasm Metastasis
Solitary Lung Metastasis of Prostate Cancer with a Long Disease-Free Interval and Normal Prostate-Specific Antigen Level.
Neoplasm Metastasis
The use of placental S100 (S100P), GATA3 and napsin A in the differential diagnosis of primary adenocarcinoma of the bladder and bladder metastasis from adenocarcinoma of the lung.
Neoplasm Metastasis
Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study.
Neoplasm Metastasis
Unexpected TTF-1 Positivity in a Subset of Gastric Adenocarcinomas.
Neoplasm Metastasis
Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma.
Neoplasm Metastasis
[A Case of Lung Metastasis Occurring Four Years after Pancreaticoduodenectomy for Pancreatic Cancer].
Neoplasm Metastasis
[A case of resectable lung metastasis one year six months after surgery for pancreatic cancer].
Neoplasms
A case of napsin A-positive metastatic lung cancer originating from the colon.
Neoplasms
A novel approach using sorafenib in alpha fetoprotein-producing hepatoid adenocarcinoma of the lung.
Neoplasms
A Rare Case of GATA3 Positivity in Pleomorphic Lung Carcinoma in a Patient with History of Intracystic Papillary Carcinoma of the Breast: Primary Lung or Metastatic Disease?
Neoplasms
A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa.
Neoplasms
A word of caution regarding napsin a expression in squamous cell carcinomas of the lung.
Neoplasms
Aberrant expression of napsin A in a subset of malignant lymphomas.
Neoplasms
Aberrant Expression of Napsin A in Breast Carcinoma With Apocrine Features.
Neoplasms
Adenocarcinoma of the thymus: mucinous subtype.
Neoplasms
ALK Rearrangements Characterize 2 Distinct Types of Salivary Gland Carcinomas: Clinicopathologic and Molecular Analysis of 4 Cases and Literature Review.
Neoplasms
ALK-positive adenocarcinoma of the lung expressing neuroendocrine markers and presenting as a "pituitary adenoma".
Neoplasms
An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung.
Neoplasms
Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.
Neoplasms
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Neoplasms
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Neoplasms
Atypical Proliferative (Borderline) Serous Tumor in the Brain: A Case Report.
Neoplasms
Automated Immunohistochemistry Assay for the Detection of Napsin-A in Formalin-Fixed Paraffin-Embedded Tissues from Lung Tumors.
Neoplasms
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Neoplasms
Calibration and Optimization of p53, WT1, and Napsin A Immunohistochemistry Ancillary Tests for Histotyping of Ovarian Carcinoma: Canadian Immunohistochemistry Quality Control (CIQC) Experience.
Neoplasms
Case Report: Next-Generation Sequencing Reveals Tumor Origin in a Female Patient With Brain Metastases.
Neoplasms
CDX-2 Expression in Primary Lung Adenocarcinoma.
Neoplasms
Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
Neoplasms
Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
Neoplasms
Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Neoplasms
Concordant clear cell "mesonephric" carcinoma of the bladder and lung adenocarcinoma with clear cell features - multiple primaries versus metastatic neoplasms: a case report.
Neoplasms
Cytopathologic features and differential diagnostic considerations of primary lymphoepithelioma-like carcinoma of the lung.
Neoplasms
Cytopathologic findings and differential diagnostic considerations of primary clear cell carcinoma of the lung.
Neoplasms
Despite Diagnostic Morphology, Many Mixed Endometrial Carcinomas Show Unexpected Immunohistochemical Staining Patterns.
Neoplasms
Diagnostic and Prognostic Role of Immunohistochemical Expression of Napsin-A Aspartic Peptidase in Clear Cell and Papillary Renal Cell Carcinoma: A Study Including 233 Primary and Metastatic Cases.
Neoplasms
Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Neoplasms
Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1?) and napsin A for diagnosing ovarian clear cell carcinoma.
Neoplasms
Difficulties of clinical and histopathological diagnosis in advanced vulvar clear cell carcinoma.
Neoplasms
Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non-small Cell Lung Cancer.
Neoplasms
Endometrial tumors with yolk sac tumor-like morphologic patterns or immunophenotypes: an expanded appraisal.
Neoplasms
Epithelial and organ-related marker expression in pituitary adenomas.
Neoplasms
Gastrointestinal hemorrhage caused by duodenal metastasis from a primary lung adenocarcinoma: A case report.
Neoplasms
Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma.
Neoplasms
Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.
Neoplasms
High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature.
Neoplasms
High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.
Neoplasms
Histopathologic, immunophenotypic and cytogenetic features of pulmonary mucoepidermoid carcinoma.
Neoplasms
Hyalinizing clear cell carcinoma of the bronchial glands: presentation of three cases and pathological comparisons with salivary gland counterparts and bronchial mucoepidermoid carcinomas.
Neoplasms
Hyalinizing Clear Cell Carcinoma of the Lung: Case Report and Review of the Literature.
Neoplasms
Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.
Neoplasms
Immunoexpression of napsin A in renal neoplasms.
Neoplasms
Immunohistochemical analysis and comparison of napsin A, TTF1, SPA and CK7 expression in primary lung adenocarcinoma.
Neoplasms
Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
Neoplasms
Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Neoplasms
Initial clinical presentation of single soft tissue metastasis of medullary thyroid carcinoma without primary tumor in the thyroid gland.
Neoplasms
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis.
Neoplasms
Leptomeningeal carcinomatosis as initial presentation in adenocarcinoma of lung with signet ring cell features: an autopsy case report.
Neoplasms
Lung metastasis from gastric cancer presenting as diffuse ground-glass opacities.
Neoplasms
Lung recurrence and its therapeutic strategy in patients with pancreatic cancer.
Neoplasms
Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.
Neoplasms
Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer.
Neoplasms
Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
Neoplasms
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Neoplasms
Napsin a and thyroid transcription factor-1-positive cerebellar tumor with epidermal growth factor receptor mutation.
Neoplasms
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Neoplasms
Napsin A as a marker of clear cell ovarian carcinoma.
Neoplasms
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Neoplasms
Napsin A Expression in Human Tumors and Normal Tissues.
Neoplasms
Napsin A expression in lung and kidney neoplasia: a review and update.
Neoplasms
Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study.
Neoplasms
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Neoplasms
Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Neoplasms
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Neoplasms
Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung.
Neoplasms
Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
Neoplasms
Napsin A staining in adrenal cortical neoplasms.
Neoplasms
Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas.
Neoplasms
Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
Neoplasms
Non-sarcomatous spindle cell morphology in conventional lung adenocarcinoma: a clinicopathological study.
Neoplasms
Occult carcinoma confirmed to be a diffuse sclerosing variant of papillary thyroid carcinoma with unusual immunohistochemical features: A pitfall of clinicopathological diagnosis.
Neoplasms
Occult ovarian clear-cell carcinoma diagnosed as primary adenocarcinoma of the lung: A case report of a diagnostic pitfall for clinicians and pathologists.
Neoplasms
Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination.
Neoplasms
Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
Neoplasms
Pepstatin pull-down at high pH is a powerful tool for detection and analysis of napsin A.
Neoplasms
Polyclonal napsin A expression: a potential diagnostic pitfall in distinguishing primary from metastatic mucinous tumors in the lung.
Neoplasms
Primary pulmonary adenocarcinoma with enteric differentiation resembling metastatic colorectal carcinoma: A report of the second case negative for cytokeratin 7.
Neoplasms
Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion, resembling extraskeletal myxoid chondrosarcoma: Case report with a review of Literature.
Neoplasms
Primary Thymic Signet Ring Cell Adenocarcinoma: A Currently Unrecognized Variant.
Neoplasms
Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study.
Neoplasms
Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations.
Neoplasms
Pulmonary Adenocarcinoma Mimicking Desquamative Interstitial Pneumonia: Report of 2 Cases With Genetic Analysis.
Neoplasms
Pulmonary Adenocarcinoma, Intra-alveolar Variant: A Rare Entity Mimicking Desquamative Interstitial Pneumonia.
Neoplasms
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Neoplasms
Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
Neoplasms
Role of Napsin A and Survivin Immunohistochemical Expression in Bronchogenic Adenocarcinoma.
Neoplasms
ROS1-rearranged high-PD-L1-expressing lung adenocarcinoma manifesting as mediastinal tumor: A case report.
Neoplasms
Sarcomatoid carcinoma in cytology: Report of a rare entity presenting in pleural and pericardial fluid preparations.
Neoplasms
Solitary Lung Metastasis of Prostate Cancer with a Long Disease-Free Interval and Normal Prostate-Specific Antigen Level.
Neoplasms
Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
Neoplasms
Surfactant Protein A and Napsin A in the Immunohistochemical Characterization of Canine Pulmonary Carcinomas: Comparison With Thyroid Transcription Factor-1.
Neoplasms
Surgical treatment of bone metastasis followed by a primary lung cancer lesion: report of a case.
Neoplasms
The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity.
Neoplasms
The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
Neoplasms
Tissue-Preserving Antibody Cocktails to Differentiate Primary Squamous Cell Carcinoma, Adenocarcinoma, and Small Cell Carcinoma of Lung.
Neoplasms
TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.
Neoplasms
TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.
Neoplasms
Unusual expression of thyroid transcription factor 1 and napsin a in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung.
Neoplasms
Utility of a Novel Triple Marker (Combination of TTF-1, Napsin-A and P40) in the Subclassification of Non-Small Cell Lung Carcinomas using Fine Needle Aspiration Cases.
Neoplasms
Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases.
Neoplasms
Well-differentiated fetal adenocarcinoma of the lung: clinicopathologic features of 45 cases in China.
Neoplasms
[A Case of Lung Metastasis Occurring Four Years after Pancreaticoduodenectomy for Pancreatic Cancer].
Neoplasms
[A Case of Metastatic Small Intestinal Tumor Diagnosed with Intestinal Obstruction].
Neoplasms
[Clear Cell Carcinoma of Cervix in a 12-Year-Old Girl: A Case Report].
Neoplasms
[Clinicopathologic features and epidermal growth factor receptor gene mutation of primary pulmonary mucoepidermoid carcinoma].
Neoplasms
[Diagnosis value of TTF-1, Napsin A and Ki-67 index in primary salivary gland-type lung carcinomas].
Neoplasms
[Diagnostic value of combined detection of HNF-1? and Napsin A in the diagnosis of ovarian clear cell carcinoma].
Neoplasms
[Fetal adenocarcinoma of the lung: a clinicopathologic analysis of six cases].
Neoplasms
[Lung Metastasis of Breast Cancer Five Years after Mastectomy - A Case Report].
Neoplasms
[Lung non-terminal respiratory unit type adenocarcinoma: a clinicopathologic study].
Neoplasms, Unknown Primary
The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
Neuroendocrine Tumors
Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
Neuroendocrine Tumors
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Neuroendocrine Tumors
Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases.
Ovarian Neoplasms
The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary.
Pancreatic Neoplasms
[A Case of Lung Metastasis Occurring Four Years after Pancreaticoduodenectomy for Pancreatic Cancer].
Pancreatic Neoplasms
[A case of resectable lung metastasis one year six months after surgery for pancreatic cancer].
Paraganglioma
Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases.
Pleural Effusion
Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.
Pleural Effusion
Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
Pleural Effusion
TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.
Pleural Effusion
Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion.
Prostatic Neoplasms
Solitary Lung Metastasis of Prostate Cancer with a Long Disease-Free Interval and Normal Prostate-Specific Antigen Level.
Proteinuria
Immunohistochemical localization of napsin and its potential role in protein catabolism in renal proximal tubules.
Pulmonary Alveolar Proteinosis
Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis.
Pulmonary Fibrosis
[Effect of Napsin A transfection into type II alveolar epithelial cells on pulmonary fibrosis].
Sarcoma
Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology.
Sarcoma
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy.
Small Cell Lung Carcinoma
IMP3 can predict aggressive behaviour of lung adenocarcinoma.
Squamous Cell Carcinoma of Head and Neck
A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa.
Thyroid Cancer, Papillary
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Thyroid Cancer, Papillary
Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Thyroid Cancer, Papillary
Napsin A Expression in Human Tumors and Normal Tissues.
Thyroid Cancer, Papillary
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Thyroid Cancer, Papillary
Occult carcinoma confirmed to be a diffuse sclerosing variant of papillary thyroid carcinoma with unusual immunohistochemical features: A pitfall of clinicopathological diagnosis.
Thyroid Neoplasms
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Thyroid Neoplasms
Initial clinical presentation of single soft tissue metastasis of medullary thyroid carcinoma without primary tumor in the thyroid gland.
Thyroid Neoplasms
Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Thyroid Neoplasms
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Thyroid Neoplasms
Occult carcinoma confirmed to be a diffuse sclerosing variant of papillary thyroid carcinoma with unusual immunohistochemical features: A pitfall of clinicopathological diagnosis.
Thyroid Neoplasms
Poorly differentiated adenocarcinoma of an unknown primary with a thyroid tumour and an aggressive course: thyroid or lung carcinoma?
Thyroid Neoplasms
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
Wilms Tumor
Metastasis of Sarcomatoid Malignant Mesothelioma With p16/CDKN2A Deletion Manifested as a Subcutaneous Mass in the Back: A Case Report and Review of Literature.
Wilms Tumor
Napsin-A, A Possible Diagnostic Marker for Differentiating Clear Cell Ovarian Carcinoma From Other High-grade Ovarian Carcinomas.
Wilms Tumor
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Wilms Tumor
Utility and pitfall of Immunohistochemistry in the Differential Diagnosis between Epithelioid Mesothelioma and Poorly Differentiated Lung Squamous Cell Carcinoma.
Wilms Tumor
Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3.4.23.B1 napsin
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
